Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Apr 1.

Published in final edited form as: J Mol Cell Cardiol. 2009 Dec 3;48(4):673–679. doi: 10.1016/j.yjmcc.2009.11.011

Data from hearts exposed to 30/30 min of ischemia/reperfusion. Representative LV Pressure (red) and ECG (blue) traces for control (A) and 4-ClDzp-treated (B) hearts. C. Arrhythmia scores for hearts exposed to ischemia and reperfusion in the absence or presence of 64μM 4-ClDzp. D. LV Developed Pressure for hearts after 30 minutes of global ischemia.

Data from hearts exposed to 30/30 min of ischemia/reperfusion. Representative LV Pressure (red) and ECG (blue) traces for control (A) and 4-ClDzp-treated (B) hearts. C. Arrhythmia scores for hearts exposed to ischemia and reperfusion in the absence or presence of 64μM 4-ClDzp. D. LV Developed Pressure for hearts after 30 minutes of global ischemia.